BIOGEN INC. Depreciation & Amortization 2007-2026 | BIIB
Beta
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is BIOGEN INC.'s current depreciation & amortization?
BIOGEN INC. (BIIB) annual depreciation & amortization for 2025 was $779.9M, a 15.85% increase from 2024. BIOGEN INC. depreciation & amortization for the quarter ending March 31, 2026 was $204.4M.
What was BIOGEN INC.'s depreciation & amortization in 2024?
BIOGEN INC. annual depreciation & amortization for 2024 was $673.2M, a 36.05% increase from 2023.
What was BIOGEN INC.'s depreciation & amortization in 2023?
BIOGEN INC. annual depreciation & amortization for 2023 was $494.8M, a 4.55% decline from 2022.
What is BIOGEN INC.'s 5-year depreciation & amortization CAGR?
BIOGEN INC. depreciation & amortization grew at a compound annual growth rate (CAGR) of 11.27% from FY2020 to FY2025, going from $457.2M to $779.9M over 5 years.
Depreciation & Amortization History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+11.3%
FY2020
$457.2M
→
FY2025
$779.9M
07080910111213141516171819202122232425
5 years selected
Depreciation & Amortization History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $779.9M | +15.8% | 10-K |
| FY2024 | $673.2M | +36.1% | 10-K |
| FY2023 | $494.8M | -4.6% | 10-K |
| FY2022 | $518.4M | +6.3% | 10-K |
| FY2021 | $487.7M | +6.7% | 10-K |
| FY2020 | $457.2M | -1.6% | 10-K |
| FY2019 | $464.7M | -28.6% | 10-K |
| FY2018 | $650.5M | -39.8% | 10-K |
| FY2017 | $1.08B | +58.3% | 10-K |
| FY2016 | $682.7M | +13.7% | 10-K |
| FY2015 | $600.4M | -12.7% | 10-K |
| FY2014 | $688.1M | +29.4% | 10-K |
| FY2013 | $531.7M | +45.4% | 10-K |
| FY2012 | $365.6M | +1.9% | 10-K |
| FY2011 | $358.9M | +0.9% | 10-K |
| FY2010 | $355.7M | -16.9% | 10-K |
| FY2009 | $428.0M | -7.4% | 10-K |
| FY2008 | $462.1M | +21.5% | 10-K |
| FY2007 | $380.3M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →